AnatomyOrganismsDiseasesChemicals and DrugsAnalytical, Diagnostic and Therapeutic Techniques and EquipmentPsychiatry and PsychologyPhenomena and ProcessesDisciplines and OccupationsAnthropology, Education, Sociology and Social PhenomenaHumanitiesInformation ScienceNamed GroupsHealth CareGeographicals
CholeraCholera ToxinCholera VaccinesVibrio choleraePrimary PreventionVibrio cholerae O1HaitiG(M1) GangliosideSecondary PreventionCenters for Disease Control and Prevention (U.S.)AntitoxinsToxoidsBangladeshVibrio cholerae O139Intestinal SecretionsEnterotoxinsDisease OutbreaksAccident PreventionAdenosine Diphosphate RiboseRisk FactorsToxins, BiologicalAdministration, OralDiarrheaSanitationCyclic AMPUnited StatesAdenylate CyclaseBacterial ToxinsHIV InfectionsEpidemicsVibrioHealth PromotionAntibodies, BacterialVaccinationPreventive Health ServicesImmunoglobulin AIncidenceTime FactorsHealth EducationHealth Knowledge, Attitudes, PracticeImmunizationGangliosidesClassical Swine FeverAdministration, IntranasalVirulence Factors, BordetellaIleumIntestinal MucosaIndiaPreventive MedicineRabbitsPertussis ToxinWater MicrobiologyPopulation SurveillanceFecesImmunity, MucosalGTP-Binding ProteinsHistory, 19th CenturyGuinea-BissauRisk Reduction BehaviorCholera MorbusVibrio cholerae non-O1Fluid TherapyPhilippinesProgram EvaluationZimbabweJejunumTreatment OutcomeRandomized Controlled Trials as TopicInfant, NewbornRisk AssessmentHygienePrevalencePasteurella multocidaVaccines, InactivatedAdenylate Cyclase ToxinPublic HealthNucleoside Diphosphate SugarsColforsinImmunoglobulin A, SecretoryWater SupplyEndemic DiseasesPregnancyQuestionnairesAntidiarrhealsBucladesineDemocratic Republic of the CongoBacterial VaccinesChemopreventionWounds and InjuriesRisk-TakingImmunoglobulin GSexual BehaviorClinical Trials as TopicDouble-Blind MethodCost-Benefit AnalysisIntestinesNeoplasmsRural PopulationFollow-Up StudiesCross-Sectional Studies